[
    "{\"step_by_step_thinking\": \"Based on the provided documents, belimumab has been shown to be effective in the treatment of lupus nephritis. Document [1] states that belimumab was found to be most effective in improving the primary efficacy kidney response and complete kidney response in patients with proliferative lupus nephritis. Document [4] also mentions that available data are promising and provide preliminary support for targeting BlyS (the target of belimumab) to induce or maintain a renal response. Additionally, Document [7] mentions that belimumab treatment improved renal response and impacted features related to kidney damage progression compared to standard therapy alone. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]